ARTICLE | Clinical News
Xerecept: Phase III started
April 26, 2004 7:00 AM UTC
NTII began a U.S. and Canadian Phase III trial in about 200 patients who are taking high doses of dexamethasone. NTII said it will start a second Phase III trial this summer in 120 steroid-naïve patie...